Prognostic factors in malignant melanoma

  • Edwin B. Cox
Part of the Developments in Oncology book series (DION, volume 5)


Some of the most substantive recent developments regarding malignant melanoma involve the elucidation of prognostic factors in the disease. Formerly, melanoma had the well-justified reputation of being a capricious, unpredictable neoplasm. The advances in prognostic classification are largely due to pathological microstaging guidelines formulated by Clark et al. and Breslow [1, 2]. Their criteria have made it possible to precisely predict which patients have almost certainly been cured by wide local excision alone, which patients are likely to have occult distant metastases with a high risk for recurrence and which patients have occult metastasis confined to regional lymph nodes. Several of the long-standing issues in treating melanoma, such as the efficacy of prophylactic lymph node dissections and the role of various modalities of adjuvant therapy, should be readily resolvable with well-designed studies involving a practical number of subjects now that it is possible to form subgroups of patients with uniform prognostic features.


Melanoma Patient Cutaneous Melanoma Wide Local Excision Nodular Melanoma Elective Lymph Node Dissection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Clark WH, From L, Bernardino E and Mihm M: The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 29:705–726, 1969.PubMedGoogle Scholar
  2. 2.
    Breslow A: Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 172:902–908, 1970.PubMedCrossRefGoogle Scholar
  3. 3.
    Lee KL, McNeer JF, Starmer CF, Harris PJ and Rosati RA: Clinical judgement and statistics. Lessons from a simulated randomized trial in coronary artery disease. Circulation 61:508–515, 1980.PubMedGoogle Scholar
  4. 4.
    Cox DR: Regression models and life tables. J R Stat Soc B 34:187–220, 1972.Google Scholar
  5. 5.
    Breslow N: Covariance analysis of censored survival data. Biometrics 30:89–100, 1974.PubMedCrossRefGoogle Scholar
  6. 6.
    Kalbfleisch JD and Prentice RL: The Statistical Analysis of Failure Time Data. John Wiley, New York, 1980.Google Scholar
  7. 7.
    Armitage P and Gehan EA: Statistical methods for the identification and use of prognostic factors. Int J Cancer 13:16–36, 1974.PubMedCrossRefGoogle Scholar
  8. 8.
    Kaplan EL and Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457–481, 1958.CrossRefGoogle Scholar
  9. 9.
    Berkson J and Gage R: Calculation of survival rates for cancer. Proc Mayo Clin 25:270–286, 1950.Google Scholar
  10. 10.
    Allen AC and Spitz S: Malignant melanoma. A clinicopathological analysis of the criteria for diagnosis and prognosis. Cancer 6:1–45, 1953.PubMedCrossRefGoogle Scholar
  11. 11.
    Shaw HM, McGovern VJ, Milton GW, Farago GA and McCarthy WH: Malignant melanoma: influence of site of lesion and age of patient in the female superiority in survival. Cancer 46:2731–2735, 1980.PubMedCrossRefGoogle Scholar
  12. 12.
    Gromet MA, Ominsky SH, Epstein WL and Blois MS: The thorax as the initial site for systemic relapse in malignant melanoma. A prospective study of 324 patients. Cancer 44:776–784, 1979.PubMedCrossRefGoogle Scholar
  13. 13.
    Sugarbaker EV and McBride CM: Melanoma of the trunk: the results of surgical excision and anatomic guidelines for predicting nodal metastasis. Surgery 80:22–30, 1976.PubMedGoogle Scholar
  14. 14.
    McNeer G and Das Gupta T: Routes of lympatic spread of malignant melanoma. Cancer 15:158–174, 1965.Google Scholar
  15. 15.
    Holmes E, Carmack MH, Morton DL, Clark W, Robinson D and Urist MM: A rational approach to the surgical management of melanoma. Ann Surg 186:481–490, 1977.PubMedCrossRefGoogle Scholar
  16. 16.
    Balch CM, Soong S-J, Murad TM, Ingalls AL and Maddox WA: A multifactorial analysis of melanoma III. Prognostic factors in melanoma patients with lymph node metastases (Stage II). Ann Surg 193:377–388, 1981.PubMedCrossRefGoogle Scholar
  17. 17.
    Hansen MG and McCarten AB: Tumor thickness and lymphocytic infiltration in malignant melanoma of the head and neck. Am J Surg 128:557–561, 1974.PubMedCrossRefGoogle Scholar
  18. 18.
    Lund RH and Ihnen M: Malignant melanoma. Clinical and pathological analysis of 93 cases. Is prophylactic lymph node dissection indicated? Surgery 38:652–659, 1955.PubMedGoogle Scholar
  19. 19.
    Lane N, Lattes R and Malm J: Clinicopathological correlations in a series of 117 malignant melanomas of the skin of adults. Cancer 11:1025–1043, 1958.PubMedCrossRefGoogle Scholar
  20. 20.
    Petersen NC, Bodenham DC and Lloyd OC: Malignant melanoma of the skin. A study of the origin, development, aetiology, spread, treatment, and prognosis. Part I. Br J Plast Surg 15:49–94, 1962.CrossRefGoogle Scholar
  21. 21.
    Mehnert JH and Heard JL: Staging of malignant melanomas by depth of invasion. A proposed index to prognosis. Am J Surg 110:168–176, 1965.PubMedCrossRefGoogle Scholar
  22. 22.
    Knutson CO, Hori JM and Spratt JS, Jr: Melanoma: Current Problems in Surgery (a series of monthly clinical monographs). Year Book Medical Publ, Chicago, 1971.Google Scholar
  23. 23.
    Perzik SL and Baum RK: Individualization in the management of melanoma: a review of 164 consecutive cases. Am Surg 35:177–180, 1969.PubMedGoogle Scholar
  24. 24.
    Davis NC, McLeod GR, Beardmore GL, Little JH, Quinn RL and Holt J: Primary cutaneous melanoma: a report from the Queensland Melanoma Project. CA Cancer J Clin 26:80–107, 1976.PubMedCrossRefGoogle Scholar
  25. 25.
    Cohen MH, Ketcham AS, Felix EL, Li S-H, Tomaszewski M-M, Costa J, Rabson AS, Simon RM and Rosenberg SA: Prognostic factors in patients undergoing lymphadenectomy for malignant melanoma. Ann Surg 186:635–642, 1977.PubMedCrossRefGoogle Scholar
  26. 26.
    Das Gupta TK: Results of treatment of 269 patients with primary cutaneous melanoma: a five year prospective study. Ann Surg 186:201–209, 1977.PubMedCrossRefGoogle Scholar
  27. 27.
    Elias EG, Didolkar MS, Goel IP, Formeister JF, Valenzuela LA, Pickren JL and Moore RH: A clinicopathologic study of prognostic factors in cutaneous malignant melanoma. Surg Gynecol Obstet 144:327–334, 1977.PubMedGoogle Scholar
  28. 28.
    Veronesi U et al: Inefficacy of immediate node dissection in Stage I melanoma of the limbs. N Engl J Med 297:627–665, 1977.PubMedCrossRefGoogle Scholar
  29. 29.
    Balch CM, Murad TM, Soong S-J, Ingalls AL, Halpern NB and Maddox WA: A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark’s and Breslow’s staging methods. Ann Surg 188:732–742, 1978.PubMedCrossRefGoogle Scholar
  30. 30.
    Olsen G: The malignant melanoma of the skin. Acta Chir Scand Suppl 365:1–222, 1966.PubMedGoogle Scholar
  31. 31.
    Bodenham DC: A study of 650 observed malignant melanomas in the southwest region. Ann R Coll Surg Engl 43:218–240, 1968.PubMedGoogle Scholar
  32. 32.
    Cochran AJ: Malignant melanoma: a review of 10 years’ experience in Glasgow, Scotland. Cancer 23:1190–1199, 1969.PubMedCrossRefGoogle Scholar
  33. 33.
    Fortner JG, Booher RJ and Pack GT: Results of groin dissection for malignant melanoma in 220 patients. Surgery 55:485–494, 1964.PubMedGoogle Scholar
  34. 34.
    U.S. Department of Health, Education and Welfare, National Institutes of Health: US Cancer Mortality by County: 1950–1969. Government Printing Office, Washington, 1974.Google Scholar
  35. 35.
    Arlington JH, III, Reed RJ, Ichinose H and Krementz ET: Plantar lentiginous melanoma: a distinctive variant of human cutaneous malignant melanoma. Am J Surg Path 1:131–143, 1977.CrossRefGoogle Scholar
  36. 36.
    Shah JP and Goldsmith HS: Prognosis of malignant melanoma in relation to clinical presentation. Am J Surg 123:286–288, 1972.PubMedCrossRefGoogle Scholar
  37. 37.
    Magnus K: Prognosis in malignant melanoma of the skin. Significance of stage of disease, anatomical site, sex, age and period of diagnosis. Cancer 40:389–397, 1977.PubMedCrossRefGoogle Scholar
  38. 38.
    Eldh J, Boeryd B and Peterson L-E: Prognostic factors in cutaneous malignant melanoma in Stage I. A clinical, morphological and multivariate analysis. Scand J Plast Reconstr Surg 12:243–255, 1978.PubMedCrossRefGoogle Scholar
  39. 39.
    Balch CM, Soong S-J, Murad TM, Ingalls AL and Maddox WA: A multifactorial analysis of melanoma. II: prognostic factors in patients with Stage I (localized) melanoma. Surgery 86:343–351, 1979.PubMedGoogle Scholar
  40. 40.
    Clark WH, Jr, Ainsworth AM, Bernardino EA, Yang C-H, Mihm MC, Jr and Reed RJ: The developmental biology of primary human malignant melanomas. Semin Oncol 2:83–103, 1975.PubMedGoogle Scholar
  41. 41.
    Reed RJ: New Concepts in Surgical Pathology of the Skin, pp 89–90. John Wiley, New York, 1976.Google Scholar
  42. 42.
    Smith JL and Stehlin JS: Spontaneous regression of primary malignant melanomas with regional metastases. Cancer 18:1399–1415, 1965.PubMedCrossRefGoogle Scholar
  43. 43.
    Wanebo HJ, Fortner JG, Woodruff J, MacLean B and Binkowski E: Selection of the optimum surgical treatment of Stage I melanoma by depth of microinvasion: use of the combined microstage technique (Clark-Breslow). Ann Surg 182:302–315, 1975.PubMedCrossRefGoogle Scholar
  44. 44.
    Breslow A: Histologic grading of melanoma by thickness. In: Kumar S (ed) Advances in Medical Oncology, Research, and Education, Vol X, pp 87–92. Proceedings of the 12th International Cancer Congress, Buenos Aires, 1978. Pergamon, New York, 1979.Google Scholar
  45. 45.
    Soong S-J: personal communication.Google Scholar
  46. 46.
    McGovern VJ, Shaw HM, Milton GW and Farago GA: Prognostic significance of the histological features of malignant melanoma. Histopathology 3:385–393, 1979.PubMedCrossRefGoogle Scholar
  47. 47.
    Gromet MA, Epstein WL and Blois MS: The regressing thin malignant melanoma. A distinctive lesion with metastatic potential. Cancer 42:2282–2292, 1978.PubMedCrossRefGoogle Scholar
  48. 48.
    Feibleman CE, Stoll H and Maize JC: Melanomas of the palm, sole, and nailbed: a clini-copathologic study. Cancer 46:2492–2504, 1980.PubMedCrossRefGoogle Scholar
  49. 49.
    Handley WS: The pathology of melanotic growths in relation to their operative treatment. Lancet 13:996–1003, 1907.Google Scholar
  50. 50.
    Southwick HW, Slaughter DP, Hinkamp JF and Johnson FE: The role of regional node dissection in the treatment of malignant melanoma. Arch Surg 85:63–69, 1962.PubMedCrossRefGoogle Scholar
  51. 51.
    Fortner JG, Woodruff J, Schottenfeld D and MacLean B: Biostatistical basis of elective node dissection for malignant melanoma. Ann Surg 186:101–103, 1977.PubMedCrossRefGoogle Scholar
  52. 52.
    Gumport SL and Harris MN: Results of regional lymph node dissection of melanoma. Ann Surg 179:105–108, 1974.PubMedCrossRefGoogle Scholar
  53. 53.
    McCarthy JA, Haagensen CD and Herter FP: The role of groin dissection in the management of melanoma of the lower extremity. Ann Surg 179:156–159, 1974.PubMedCrossRefGoogle Scholar
  54. 54.
    McNeer G and Das Gupta TK: Prognosis in malignant melanoma. Surgery 56:512–518, 1964.Google Scholar
  55. 55.
    Sim FH, Taylor WF, Ivins JC, Pritchard DJ and Soule EH: A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Preliminary results. Cancer 41:948–956, 1978.PubMedCrossRefGoogle Scholar
  56. 56.
    Soong S-J: personal communication.Google Scholar
  57. 57.
    Balch CM, Murad TM, Soong S-J, Ingalls AL, Richards PC and Maddox WA: Tumor thickness as a guide to surgical management of clinical Stage I melanoma patients. Cancer 43:883–888, 1979.PubMedCrossRefGoogle Scholar
  58. 58.
    Myers MH and Hankey BF: Cancer patient survival experience: trends in survival 1960–63 to 1970–73. U.S. Department of Health and Human Services, NIH Publication No 80–2148, 1980.Google Scholar
  59. 59.
    Taylor WF, Ivins JC, Dahlin DC and Pritchard DJ: Osteogenic sarcoma experience at the Mayo Clinic, 1963–1974. In: Terry WD and Windhorst D (eds) Immunotherapy of Cancer: Present Status of Trials in Man, pp 257–269. Raven, New York, 1978.Google Scholar
  60. 60.
    Rogentine GN, Jr, Van Kämmen DP, Fox BH, Docherty JP, Rosenblatt JE, Boyd SC and Bunney WE, Jr: Psychological factors in the prognosis of malignant melanoma: a prospective study. Psychosom Med 41:647–655, 1979.PubMedGoogle Scholar
  61. 61.
    McCarty KS, Jr: personal communication.Google Scholar
  62. 62.
    Karakousis CP, Stahl L, Moore R and Holyoke ED: Lymph node dissection in malignant melanoma. J Surg Oncol 13:245–252, 1980.PubMedCrossRefGoogle Scholar
  63. 63.
    Balch CM, Wilkerson JA, Murad TM, Soong S-J, Ingalls AL and Maddox WA: The prognostic significance of ulceration of cutaneous melanoma. Cancer 45:3012–3017, 1980.PubMedCrossRefGoogle Scholar
  64. 64.
    Day CL, Jr, Sober AJ, Lew RA, Mihm MC, Jr et al: Malignant melanoma patients with positive nodes and relatively good prognoses: microstaging retains prognostic significance in clinical Stage I melanoma patients with metastases to regional nodes. Cancer 47:955–962, 1981.PubMedCrossRefGoogle Scholar
  65. 65.
    Einhorn LH et al: Prognostic correlations and response to treatment in advanced metastatic malignant melanoma. Cancer Res 34:1995–2004, 1974.PubMedGoogle Scholar
  66. 66.
    Patel JK, Didolkar, MS, Pickren JW and Moore RH: Metastatic pattern of malignant melanoma. A study of 216 autopsy cases. Am J Surg 135:807–810, 1978.PubMedCrossRefGoogle Scholar
  67. 67.
    Das Gupta T and Brasfield R: Metastatic melanoma. A clinicopathological study. Cancer 17:1323–1339, 1964.CrossRefGoogle Scholar
  68. 68.
    Lee Y-T N (M): Malignant melanoma: pattern of metastasis. CA Cancer J Clin 30:137–142, 1980.PubMedCrossRefGoogle Scholar
  69. 69.
    American Joint Committee: Manual for Staging of Cancer. American Joint Committee for Cancer Staging and End-Results Reporting, Chicago, 1978.Google Scholar
  70. 70.
    Cox EB, Laszlo J and Freiman A: Classification of cancer patients: beyond TNM. J Am Med Assoc 242:2691–2695, 1979.CrossRefGoogle Scholar
  71. 71.
    Peto R, Pike MC, Armitage P, Breslow NE et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II: analysis and examples. Br J Cancer 35:1–39, 1977.PubMedCrossRefGoogle Scholar
  72. 72.
    McGovern VJ: Malignant Melanoma: Clinical and Histological Diagnosis, p 125. John Wiley, New York, 1976.Google Scholar

Copyright information

© Martinus Nijhoff Publishers, The Hague/Boston/London 1982

Authors and Affiliations

  • Edwin B. Cox

There are no affiliations available

Personalised recommendations